Last reviewed · How we verify
NCT06949592: BIOLEMON
Oral Bioavailability of the Phenolic Compounds in a Melissa Supplement
NA trial testing Placebo in Nutrition, Healthy in 10 participants. Completed in 12 June 2025.
12 June 2025
Quick facts
| Lead sponsor | Fytexia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 30 April 2025 |
| Primary completion | 12 June 2025 |
| Estimated completion | 12 June 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Placebo
- M_ML
- M_ML
Conditions studied
- Nutrition, Healthy — all drugs for Nutrition, Healthy →
Sponsor
Fytexia
Who can join
Adults 18 to 60, any sex, with Nutrition, Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to identify phenolic compound biomarkers of the intake of a mixture of Melissa officinalis extract, acerola extract and vitamin B5. This will be done through the study of their bioavailability and nutrikinetics by measuring their plasma concentrations and urinary excretion over 24h by means of high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). The study follows a cross-over, double-blind, randomized and placebo control design on 10 healthy subjects
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06949592
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrition, Healthy
Currently open trials in the same condition.
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
- NCT07054294 — Total Energy Expenditure Across the Life Course in Low-and Middle-Income Countries -- Chinese Children · recruiting
- NCT07056504 — Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation · recruiting
Other Fytexia trials
Trials by the same sponsor.
- NCT06062511 — Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies · NA · completed
- NCT05926947 — OXXYNEA® GS: Study for Glycaemia Management · NA · active not recruiting
- NCT05598749 — Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study · NA · completed
- NCT04914416 — Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects · NA · completed
- NCT04765189 — Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06949592 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fytexia
- Last refreshed: 15 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06949592.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing